Free Access

This article has an erratum: [https://doi.org/10.1051/ject/201547251]


Issue
J Extra Corpor Technol
Volume 47, Number 2, June 2015
Page(s) 83 - 89
DOI https://doi.org/10.1051/ject/201547083
Published online 15 June 2015
  1. Landis CR, Murkin JM, Stump DA, et al. Consensus statement: Minimal criteria for reporting the systemic inflammatory response to cardiopulmonary bypass. Heart Surg Forum. 2010;13:E116–123. [Google Scholar]
  2. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83(Suppl 5):S27–86. [CrossRef] [Google Scholar]
  3. Snyder-Ramos SA, Mohnle P, Weng YS, et al. The ongoing variability in blood transfusion practices in cardiac surgery. Transfusion. 2008;48:1284–1299. [CrossRef] [PubMed] [Google Scholar]
  4. Shander A, Puzio T, Javidroozi M. Variability in transfusion practice and effectiveness of strategies to improve it. J Cardiothorac Vasc Anesth. 2012;26:541–544. [CrossRef] [Google Scholar]
  5. Bennett-Guerrero E, Zhao Y, O’Brien SM, et al. Variation in use of blood transfusion in coronary artery bypass graft surgery. JAMA. 2010;304:1568–1575. [CrossRef] [PubMed] [Google Scholar]
  6. Stover EP, Siegel LC, Parks R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: A 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology. 1998;88:327–333. [CrossRef] [PubMed] [Google Scholar]
  7. Spiess BD, Ley C, Body SC, et al. Hematocrit value on intensive care unit entry influences the frequency of Q-wave myocardial infarction after coronary artery bypass grafting. The Institutions of the Multicenter Study of Perioperative Ischemia (McSPI) Research Group. J Thorac Cardiovasc Surg. 1998;116:460–467. [CrossRef] [Google Scholar]
  8. Loor G., Li L, Sabik JFIII, et al., Nadir hematocrit during cardiopulmonary bypass: End-organ dysfunction and mortality. J Thorac Cardiovasc Surg. 2012;144:654–662. [CrossRef] [Google Scholar]
  9. Likosky DS, Surgenor SD, Dacey LJ, et al. Rationalising the treatment of anaemia in cardiac surgery: Short and mid-term results from a local quality improvement initiative. Qual Saf Health Care. 2010;19:392–398. [PubMed] [Google Scholar]
  10. Ranucci M, Castelvecchio S, Ditta A, et al. Transfusions during cardiopulmonary bypass: Better when triggered by venous oxygen saturation and oxygen extraction rate. Perfusion. 2011;26:327–333. [CrossRef] [PubMed] [Google Scholar]
  11. Kiers HD, van der Boogaard M, Schoenmakers MC, et al. Comparison and clinical suitability of eight prediction models for cardiac surgery related acute kidney injury. Nephrol Dial Transplant. 2013;28:345–351. [CrossRef] [PubMed] [Google Scholar]
  12. Likosky DS, FitzGerald DC, Groom RC, et al. The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. J Extra Corpor Technol. 2010;42:114–121. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. DioDato CP, Likosky DS, DeFoe GR, et al. Cardiopulmonary bypass recommendations in adults: The northern New England experience. J Extra Corpor Technol. 2008;40:16–20. [Google Scholar]
  14. Warren CS, DeFoe GR, Groom RC, et al. Variation in arterial inflow temperature: A regional quality improvement project. J Extra Corpor Technol. 2011;43:58–63. [Google Scholar]
  15. Baker RA, Newland RF, Fenton C, et al. Developing a benchmarking process in perfusion: A report of the Perfusion Downunder Collaboration. J Extra Corpor Technol. 2012;44:26–33. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  16. Vamvakas EC, Taswell HF. Long-term survival after blood transfusion. Transfusion. 1994;34:471–477. [CrossRef] [PubMed] [Google Scholar]
  17. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608–1616. [CrossRef] [PubMed] [Google Scholar]
  18. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–2552. [CrossRef] [PubMed] [Google Scholar]
  19. Paone G, Likosky LS, Brewer R, et al. Transfusion of 1 and 2 units of red blood cells is associated with increased morbidity and mortality. Ann Thorac Surg. 2014;97:87–93, discussion 93–94. [CrossRef] [Google Scholar]
  20. Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg. 2009;108:1741–1746. [CrossRef] [PubMed] [Google Scholar]
  21. Jin R, Zelinka ES, McDonald J, et al. Effect of hospital culture on blood transfusion in cardiac procedures. Ann Thorac Surg. 2013;95:1269–1274. [CrossRef] [Google Scholar]
  22. Scott BH, Seifert FC, Glass PS, Grimson R. Blood use in patients undergoing coronary artery bypass surgery: Impact of cardiopulmonary bypass pump, hematocrit, gender, age, and body weight. Anesth Analg. 2003;97:958–963. [CrossRef] [PubMed] [Google Scholar]
  23. Edwards FH, Ferraris VA, Shahian DM, et al. Gender-specific practice guidelines for coronary artery bypass surgery: Perioperative management. Ann Thorac Surg. 2005;79:2189–2194. [CrossRef] [Google Scholar]
  24. Salis S, Mazzanti VV, Merli G, et al. Cardiopulmonary bypass duration is an independent predictor of morbidity and mortality after cardiac surgery. J Cardiothorac Vasc Anesth. 2008;22:814–822. [CrossRef] [Google Scholar]
  25. Nissinen J, Biancari F, Wistbacka JO, et al. Safe time limits of aortic cross-clamping and cardiopulmonary bypass in adult cardiac surgery. Perfusion. 2009;24:297–305. [CrossRef] [PubMed] [Google Scholar]
  26. Engoren M, Schwann TA, Habib RH, Neill SN, Vance JL, Likosky DS. The independent effects of anemia and transfusion on mortality after coronary artery bypass. Ann Thorac Surg. 2014;97:514–520. [CrossRef] [Google Scholar]
  27. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944–982. [CrossRef] [Google Scholar]
  28. Whitlock R, Mathew J, Eikelboom J, Al-Saleh AM, Yuan F, Teoh K. Processed residual pump blood in cardiac surgery: The processed residual blood in cardiac surgery trial. Transfusion. 2013;53:1487–1492. [CrossRef] [PubMed] [Google Scholar]
  29. McNair E, McKay W, Qureshi AM, Rosin M, et al. Outcomes and biochemical parameters following cardiac surgery: Effects of transfusion of residual blood using centrifugation and multiple-pass hemoconcentration. J Cardiothorac Vasc Anesth. 2013;27:1174–1180. [CrossRef] [Google Scholar]
  30. Hillis LD, Smith PK, Anderson JL, et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2012;143:4–34. [CrossRef] [Google Scholar]
  31. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;CD001886. [Google Scholar]
  32. Wahr JA, Prager RL, Abernathy JH, et al. Patient safety in the cardiac operating room: Human factors and teamwork: A scientific statement from the American Heart Association. Circulation. 2013;128:1139–1169. [CrossRef] [PubMed] [Google Scholar]
  33. Thenappan T, Swamy R, Shah A, et al. Interchangeability of activated clotting time values across different point-of-care systems. Am J Cardiol. 2012;109:1379–1382. [CrossRef] [Google Scholar]
  34. Svenmarker S, Appelblad M, Jansson E, Haggmark S. Measurement of the activated clotting time during cardiopulmonary bypass: Differences between Hemotec ACT and Hemochron Jr apparatus. Perfusion. 2004;19:289–294. [CrossRef] [PubMed] [Google Scholar]
  35. O’Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 2—Isolated valve surgery. Ann Thorac Surg. 2009;88(Suppl):S23–42. [CrossRef] [Google Scholar]
  36. Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–744, discussion 744–745. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.